Your browser doesn't support javascript.
loading
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Cancer Discov ; 1(6): 508-23, 2011 Nov.
Article in En | MEDLINE | ID: mdl-22586653

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Receptor, ErbB-2 / Xenograft Model Antitumor Assays / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Cancer Discov Year: 2011 Document type: Article Affiliation country: Italy Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Receptor, ErbB-2 / Xenograft Model Antitumor Assays / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Cancer Discov Year: 2011 Document type: Article Affiliation country: Italy Country of publication: United States